FNA
TMO icon

First National Advisers’s Thermo Fisher Scientific TMO Stock Holding History

First National Advisers’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.14M Sell
6,379
-267
-4% -$145K 0.46% 58
2025
Q4 		$3.85M Buy
6,646
+3,639
+121% +$2.06M 0.53% 46
2025
Q3 		$1.46M Sell
3,007
-228
-7% -$106K 0.2% 116
2025
Q2 		$1.31M Sell
3,235
-4,663
-59% -$1.95M 0.19% 120
2025
Q1 		$3.93M Sell
7,898
-55
-0.7% -$29.8K 0.63% 44
2024
Q4 		$4.14M Sell
7,953
-838
-10% -$461K 0.67% 37
2024
Q3 		$5.44M Buy
8,791
+412
+5% +$244K 0.87% 24
2024
Q2 		$4.63M Buy
8,379
+1,311
+19% +$751K 0.85% 25
2024
Q1 		$4.1M Buy
7,068
+856
+14% +$480K 0.92% 23
2023
Q4 		$3.3M Buy
6,212
+1,933
+45% +$936K 0.95% 23
2023
Q3 		$2.17M Buy
4,279
+1,773
+71% +$945K 0.97% 22
2023
Q2 		$1.31M Buy
2,506
+125
+5% +$67.5K 1.2% 22
2023
Q1 		$1.37M Buy
2,381
+175
+8% +$98.6K 1.56% 15
2022
Q4 		$1.22M Buy
2,206
+237
+12% +$126K 1.56% 17
2022
Q3 		$999K Buy
1,969
+554
+39% +$310K 1.48% 11
2022
Q2 		$769K Buy
+1,415
New +$779K 1.6% 10

Other funds holding TMO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

First National Advisers's TMO Position: Q1 2026 in Review

First National Advisers reduced its Thermo Fisher Scientific (TMO) stake by 4% in Q1 2026, selling an estimated $145K and leaving 6,379 shares worth $3.14M. The position accounts for 0.46% of the portfolio, ranked #58.

First National Advisers first reported a position in TMO in Q2 2022 and has held it in 16 quarters since. The position peaked at $5.44M in Q3 2024. 2,587 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

  • First National Advisers held 6,379 shares of Thermo Fisher Scientific worth $3.14M as of Q1 2026.
  • First National Advisers sold 267 Thermo Fisher Scientific shares in Q1 2026, an estimated $145K.
  • Thermo Fisher Scientific made up 0.46% of First National Advisers's portfolio in Q1 2026, its #58 holding.
  • First National Advisers first reported a position in Thermo Fisher Scientific in Q2 2022 and has held it in 16 quarters since.
  • First National Advisers's Thermo Fisher Scientific position peaked at $5.44M in Q3 2024.
  • 2,587 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on First National Advisers's 13F filing for Q1 2026, filed 8 May 2026.